Noesis Capital Mangement Corp Novartis Ag Transaction History

Noesis Capital Mangement Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $196,225 - $231,404	-2,350 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$78.07 - $94.43 $23,420 - $28,329	-300 Reduced 11.32%	2,350 $221,000
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $30,160 - $37,120	-400 Reduced 13.11%	2,650 $0
Q1 2019 May 09, 2019	SELL	$75.32 - $86.15 $25,608 - $29,291	-340 Reduced 10.03%	3,050 $0
Q4 2018 Feb 08, 2019	BUY	$73.66 - $82.02 $40,513 - $45,111	550 Added 19.37%	3,390 $291,000
Q1 2018 May 07, 2018	SELL	$70.39 - $84.15 $67,785 - $81,036	-963 Reduced 25.32%	2,840 $230,000
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $1,446 - $1,552	-20 Reduced 0.52%	3,803 $319,000
Q3 2017 Nov 07, 2017	BUY	$74.14 - $77.27 $5,189 - $5,408	70 Added 1.87%	3,823 $328,000
Q2 2017 Aug 10, 2017	BUY	N/A	3,753	3,753 $313,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

Stay updated on Noesis Capital Mangement Corp with notifications on news.